IRIS
LEUCI, ROSALBA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 668
AS - Asia 623
EU - Europa 494
SA - Sud America 131
AF - Africa 22
Totale 1.938
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 645
SG - Singapore 283
IT - Italia 151
BR - Brasile 119
CN - Cina 105
RU - Federazione Russa 95
HK - Hong Kong 83
VN - Vietnam 64
DE - Germania 57
SE - Svezia 45
FR - Francia 40
IN - India 39
GB - Regno Unito 35
ID - Indonesia 19
AT - Austria 16
CA - Canada 15
FI - Finlandia 9
PT - Portogallo 8
CI - Costa d'Avorio 7
PL - Polonia 7
AR - Argentina 6
BD - Bangladesh 6
ES - Italia 6
LT - Lituania 6
MX - Messico 6
TR - Turchia 6
ZA - Sudafrica 6
JP - Giappone 5
UA - Ucraina 5
BE - Belgio 3
CH - Svizzera 3
EC - Ecuador 3
EG - Egitto 3
NL - Olanda 3
AE - Emirati Arabi Uniti 2
CL - Cile 2
IQ - Iraq 2
KR - Corea 2
PH - Filippine 2
TH - Thailandia 2
AL - Albania 1
BG - Bulgaria 1
CR - Costa Rica 1
CV - Capo Verde 1
DK - Danimarca 1
ET - Etiopia 1
IE - Irlanda 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
NP - Nepal 1
RS - Serbia 1
SN - Senegal 1
VE - Venezuela 1
ZW - Zimbabwe 1
Totale 1.938
Salva come PNG Salva come JPEG
Città #
Singapore 143
Ashburn 128
Hong Kong 82
Chandler 69
Beijing 58
Nyköping 45
New York 34
Dallas 29
Ho Chi Minh City 25
Los Angeles 25
Bari 21
Fragagnano 21
Munich 21
Fairfield 17
Hanoi 15
Marseille 15
Jakarta 14
Houston 13
São Paulo 13
Chennai 12
Frankfurt am Main 12
Milan 12
Moscow 12
Naples 12
Redondo Beach 11
Seattle 11
Cambridge 10
Lawrence 10
Santa Clara 10
Atlanta 9
Falkenstein 9
London 9
Roxbury 9
Chicago 8
Denver 8
Inglewood 8
Lisbon 8
Montreal 8
North Bergen 8
Abidjan 7
Brooklyn 7
Council Bluffs 7
Helsinki 7
Kolkata 7
Langenzersdorf 7
Nuremberg 7
Patna 7
Poplar 7
Johannesburg 6
Warsaw 6
Wilmington 6
Woodbridge 6
Belo Horizonte 5
Brindisi 5
Lauterbourg 5
San Francisco 5
Tokyo 5
Wuxi 5
Ancona 4
Bandung 4
Boydton 4
Da Nang 4
Düsseldorf 4
Gravina in Puglia 4
Manchester 4
Rio de Janeiro 4
Salerno 4
Vienna 4
Ankara 3
Ann Arbor 3
Araras 3
Bitonto 3
Boston 3
Brussels 3
Bucha 3
Buffalo 3
Elk Grove Village 3
Florence 3
Guangzhou 3
Guarulhos 3
Haiphong 3
Lecce 3
Maricá 3
Oklahoma City 3
Orem 3
Ottawa 3
Raleigh 3
Shanghai 3
Valencia 3
Aracaju 2
Boardman 2
Bokaro 2
Brasília 2
Cairo 2
Calgary 2
Camden 2
Camerino 2
Campina Grande 2
Carney 2
Chandigarh 2
Totale 1.226
Salva come PNG Salva come JPEG
Nome #
A Review of Recent Patents (2016-2019) on Plant Food Supplements with Potential Application in the Treatment of Neurodegenerative and Metabolic Disorders 142
Importance of Biometals as Targets in Medicinal Chemistry: An Overview about the Role of Zinc (II) Chelating Agents 103
A Chemoinformatics Search for Peroxisome Proliferator-Activated Receptors Ligands Revealed a New Pan-Agonist Able to Reduce Lipid Accumulation and Improve Insulin Sensitivity 96
A New Series of Aryloxyacetic Acids Endowed with Multi-Target Activity towards Peroxisome Proliferator-Activated Receptors (PPARs), Fatty Acid Amide Hydrolase (FAAH), and Acetylcholinesterase (AChE) 94
A NEW ANTIDIABETIC AGENT SHOWING PPARα/γ DUAL AGONISM AND MITOCHONDRIAL PYRUVATE CARRIER INHIBITION 83
A Chemical Modification of a Peroxisome Proliferator-Activated Receptor Pan Agonist Produced a Shift to a New Dual Alpha/Gamma Partial Agonist Endowed with Mitochondrial Pyruvate Carrier Inhibition and Antidiabetic Properties 82
Natural Compounds for the Prevention and Treatment of Cardiovascular and Neurodegenerative Diseases 78
A New Antidiabetic Agent Showing Short- and Long-Term Effects Due to Peroxisome Proliferator-Activated Receptor Alpha/Gamma Dual Agonism and Mitochondrial Pyruvate Carrier Inhibition 76
Can foods influence the onset and progress of neurodegenerative diseases? 71
IDENTIFICATION OF A NOVEL PPARRα/γ DUAL AGONIST SHOWING ANTIDIABETIC EFFECTS AND ABLE TO BIND TO CANONICAL AND ALLOSTERIC SITES OF ABLE TO BIND TO CANONICAL AND ALLOSTERIC SITES OF PPARγ 68
Structure-based design of novel donepezil-like hybrids for a multi-target approach to the therapy of Alzheimer's disease 68
Rivastigmine structure-based hybrids as potential multi-target anti-Alzheimer’s drug candidates 68
Food Industry Byproducts as Starting Material for Innovative, Green Feed Formulation: A Sustainable Alternative for Poultry Feeding 67
Novel Phenothiazine/Donepezil-Like Hybrids Endowed with Antioxidant Activity for a Multi-Target Approach to the Therapy of Alzheimer’s Disease 63
3-((2-(4-Chloro-5-ethoxy-2-nitrophenoxy)acetamido)methyl)phenyl-dimethylcarbamate 63
Green Methods to Recover Bioactive Compounds from Food Industry Waste: A Sustainable Practice from the Perspective of the Circular Economy 62
Repurposing Rivastigmine Anti-AD Drug By Aryloxyacetic Hybridization: Biometal Chelation And Potential Increased Anti-Amyloidogenic Ability 60
Multiple causes, multiple targets: FAAH as a centerpiece for therapy of multifactorial pathologies. 57
Multi-Target Approach for the Design of New Compounds Potentially Useful for the Prevention and Treatment of Cardiovascular and/or Neurodegenerative Diseases 54
New rivastigmine-like compounds for the potential treatment of Alzheimer’s disease: a multi-target approach 51
From classical MTDLs to a semi-synthetic innovative green approach: nature-inspired design as a new intriguing opportunity for new anti-Alzheimer’s drugs 51
Multi-target approach for the treatment of chronic and degenerative diseases 47
Rivastigmine-based hybrids: a multi-target approach to anti-Alzheimer’s drug design 46
Nature-inspired structures for the multi-target treatment of Alzheimer’s disease: a successful approach for drug design 44
New phenothiazine-donepezil like hybrids as potential Alzheimer’s disease multitarget drugs with antioxidant properties 42
A new series of rivastigmine structure-based hybrids for a multi-target approach to Alzheimer’s disease 38
Role of copper chelating agents: between old applications and new perspectives in neuroscience 36
N-(2-(Benzylamino)ethyl)-4-(naphthalene-1-sulfonamido)benzamide 34
PROTEIN MISFOLDING AND AGGREGATION CONTROL AS THE KEY TARGETS FOR INNOVATIVE MULTIFUNCTIONAL ANTI-AD SMALL MOLECULES-BASED DRUGS 29
Deep Eutectic Solvents (DESs) as Alternative Sustainable Media for the Extraction and Characterization of Bioactive Compounds from Winemaking Industry Wastes 28
Novel rivastigmine structure-based hybrids for the potential treatment of Alzheimer’s disease 24
Sustainable valorization of grape pomace as source of nutraceuticals 17
Green solvents as an alternative, sustainable practice for the recovery of phenolic compounds in grape pomace 17
A new potent and selective peroxisome proliferator-activated receptor alpha partial agonist displays anti-steatotic effects In vitro and behaves as a safe hypolipidemic and hypoglycemic agent in a diabetic mouse model 17
Grape pomace as a valuable source of nutraceuticals in Deep Eutectic Solvents ready-to-use extracts 14
New rivastigmine structure-based hybrids as potential multi-target anti-Alzheimer drugs 14
Sustainable Solutions for the Production of New Feed Supplements From Wine Industry Waste 14
Nature-inspired design of new anti-Alzheimer’s multi-target drugs: the NInFA project 11
Green methods for the recovery of bioactive molecules from natural sources 10
Valorisation of grape pomace as source of bioactive compounds in Deep Eutectic Solvents ready-to-use extracts 9
2- Aryloxymethylene-substituted scaffolds as privileged moieties for the design of new potential metal chelators in the multi-target therapy of Alzheimer's disease 8
Deep Eutectic Solvents as Convenient Media for the Preparation of Semi-synthetic Anti-AD Multi-Target Hybrids 8
Improved 2-aryloxymethylene moieties as novel potential chelators for the multi-target treatment of Alzheimer’s disease 7
Totale 2.071
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.387
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.387
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202141 0 0 0 0 0 5 8 3 5 18 0 2
2021/202260 8 0 0 0 0 8 0 3 7 5 11 18
2022/2023184 11 29 8 10 14 29 1 27 38 6 5 6
2023/2024136 9 16 6 3 15 35 6 1 14 10 6 15
2024/2025762 59 30 53 38 43 33 104 78 31 62 77 154
2025/2026862 197 81 76 259 241 8 0 0 0 0 0 0
Totale 2.071